Overview
Michael Petroziello is a Radiologist and an Interventional Radiologist in Buffalo, New York. Dr. Petroziello is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Progressive Familial Intrahepatic Cholestasis Type 1, Progressive Familial Intrahepatic Cholestasis Type 2, Neuroendocrine Tumor, Gastrostomy, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
565 Abbott Rd, Buffalo, NY 14220
1540 Maple Rd, Williamsville, NY 14221
3435 Bailey Ave, Buffalo, NY 14215
Elm And Carlton St, Buffalo, NY 14263
2157 Main St, Buffalo, NY 14214
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Limited To Official Government Duties On
Alan Klitzke is a Radiologist in Buffalo, New York. Dr. Klitzke is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Classical Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), and Smoldering Multiple Myeloma.
Roswell Park Cancer Institute
Thomas Laudico is a Radiologist in Buffalo, New York. Dr. Laudico is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Mantle Cell Lymphoma (MCL), ALK-Positive Non-Small Cell Lung Cancer, and Fibrolamellar Carcinoma.
Roswell Park Cancer Institute
Omar Hasan is a Radiologist and an Interventional Radiologist in Buffalo, New York. Dr. Hasan is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Neuroendocrine Tumor, and Fibrolamellar Carcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Neuroendocrine TumorDr. Petroziello isDistinguished. Learn about Neuroendocrine Tumor.
- Progressive Familial Intrahepatic Cholestasis Type 1Dr. Petroziello isDistinguished. Learn about Progressive Familial Intrahepatic Cholestasis Type 1.
- Progressive Familial Intrahepatic Cholestasis Type 2Dr. Petroziello isDistinguished. Learn about Progressive Familial Intrahepatic Cholestasis Type 2.
- Advanced
- Bladder CancerDr. Petroziello isAdvanced. Learn about Bladder Cancer.
- Familial Pancreatic CancerDr. Petroziello isAdvanced. Learn about Familial Pancreatic Cancer.
- Fibrolamellar CarcinomaDr. Petroziello isAdvanced. Learn about Fibrolamellar Carcinoma.
- Lung CancerDr. Petroziello isAdvanced. Learn about Lung Cancer.
- Muscle Invasive Bladder CancerDr. Petroziello isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Petroziello isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Petroziello isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Bone Marrow AspirationDr. Petroziello isExperienced. Learn about Bone Marrow Aspiration.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Petroziello isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Colorectal CancerDr. Petroziello isExperienced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Petroziello isExperienced. Learn about EGFR Positive Lung Cancer.
- Familial Colorectal CancerDr. Petroziello isExperienced. Learn about Familial Colorectal Cancer.